Clinical Trials
32 trialsNivolumab + Docetaxel + ADT in mHSPC Patients With DDRD or Inflamed Tumors
Dana-Farber Cancer Institute
RADVAN
Sun Yat-sen University
TITAN
Aragon Pharmaceuticals, Inc.
A Study of Apalutamide in Chinese Participants With Non Metastatic Castration Resistant Prostate Cancer (NM-CRPC)
Janssen Research & Development, LLC
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Radiation Therapy Oncology Group
PROTEUS
Janssen Research & Development, LLC
KNIGHTS
University of Maryland, Baltimore
A Study of ARV-766 Given by Mouth in Men With Metastatic Prostate Cancer
Novartis
Adaptive Stereotactic Body Radiation Therapy to the Prostate and Pelvic Nodes With Simultaneous Integrated Boost to the MR-detected Nodule for Patients With High-risk and Unfavorable Intermediate-risk Prostate Cancer
Washington University School of Medicine
A Comparative Dose-finding Study of RS-113 in Patients With Metastatic Castration-resistant Prostate Cancer
R-Pharm
Prostate005
University of Virginia
China ARCHES
Astellas Pharma Inc
Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel
Eastern Cooperative Oncology Group
Combination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation Therapy
H. Lee Moffitt Cancer Center and Research Institute
Imaging and Genomic Biomarkers to Predict Response in Prostate Cancer
University of Wisconsin, Madison
LIBERTAS
Janssen Research & Development, LLC
Focal Radiation With Pulsed Systemic Therapy of Abiraterone, Androgen Deprivation Therapy (ADT), Lynparza Towards Castration Sensitive Oligometastatic Prostate Cancer (FAALCON)
University of Michigan Rogel Cancer Center
Stereotactic Body Radiation Therapy in Treating Patients With Localized High-Risk Prostate Cancer
Jonsson Comprehensive Cancer Center
Therapeutic Effect of Cytoreductive Radical Prostatectomy in Men With Newly Diagnosed Metastatic Prostate Cancer
Yale University
Advanced ChemoHormonal Therapy for Treatment Naive Metastatic Prostate Cancer
OHSU Knight Cancer Institute
g-RAMPP
Martini-Klinik am UKE GmbH
HypoFocal SRT
Insel Gruppe AG, University Hospital Bern
Stereotactic Body Radiation Therapy in Treating Patients With Localized Prostate Cancer That Have Undergone Surgery
Jonsson Comprehensive Cancer Center
A Study of Shorter Course Hormone Therapy and Radiation for High-risk Prostate Cancer
Memorial Sloan Kettering Cancer Center
RAD 2003
University of Alabama at Birmingham
IOSCAR
Istituto Clinico Humanitas
ARASAFE
Jena University Hospital
Comparative Study of Radiotherapy Treatments to Treat High Risk Prostate Cancer Patients
Sir Mortimer B. Davis - Jewish General Hospital
STORM
University Hospital, Ghent
PEACE1
UNICANCER
STAMPEDE
Medical Research Council
Hypo-Combi
German Oncology Center, Cyprus